Kane Biotech Announces Exercise of Warrants
12 sept. 2024 08h30 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces the exercise of an aggregate of 5 million warrants at an...
OMINQ Secures Over $1 Million in New Purchase Orders from Prominent Bioscience Company
11 sept. 2024 08h30 HE
|
omniQ Corp.
OMNIQ secures $1M+ in new orders from a key bioscience partner, celebrating 20 years of collaboration and boosting global innovation with AI solutions.
Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD
11 sept. 2024 08h00 HE
|
Halberd Corp.
Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD
SOLASTA Bio Completes $14m Series A to Accelerate Nature-Inspired Crop Protection
11 sept. 2024 04h51 HE
|
SOLASTA Bio Ltd.
SOLASTA Bio, a leading agri-biotech company specialising in the next generation of green insecticides, has completed an oversubscribed $14 million Series A
Culture Biosciences and Google Cloud Announce Collaboration to Revolutionize Bioprocess Development
10 sept. 2024 10h00 HE
|
Culture Biosciences
SAN FRANCISCO, CALIFORNIA, UNITED STATES, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Culture Biosciences—a leader in automated bioprocess development, optimization and data science —announces a strategic...
Tersa Earth Partners with Wet’suwet’en First Nation to Advance Sustainable Economic Growth
10 sept. 2024 09h03 HE
|
Tersa Earth Innovations Inc
Tersa Earth Innovations Inc. is excited to announce a strategic partnership with Yinka Dene Economic Development Limited Partnership (YLP).
Abivax presents first-half 2024 financial results
09 sept. 2024 16h01 HE
|
Abivax
Abivax presents first-half 2024 financial results Cash balance of EUR 222M at June 30, 2024; cash runway in to Q4 2025 PARIS, France, September 9, 2024, 10:00 p.m. CEST – Abivax SA...
New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies
05 sept. 2024 16h01 HE
|
Vor Biopharma
Trem-cel + Mylotarg demonstrated engraftment, shielding, broadened therapeutic window, and patient benefitVCAR33ALLO demonstrates encouraging biomarker data at lowest dose New asset VADC45 with...
BioNTX Unveils 2024 Rising Stars at the iC³® Life Science & Healthcare Innovation Summit
05 sept. 2024 11h06 HE
|
BioNTX
IRVING, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- As Texas continues to grow as a biotech and healthcare innovative hub, BioNTX is honored to announce the 2024 Rising Stars, a select group of...
Blue Mountain and RCM Technologies Partner to Elevate Enterprise Asset Management in Life Sciences with Pre-Validated Software and Unparalleled Domain Expertise
05 sept. 2024 09h00 HE
|
Blue Mountain
Blue Mountain & RCM Technologies join forces to deliver cutting-edge EAM solutions, tailored for life sciences with pre-validated software & expert service